Suppr超能文献

基于亮氨酸拉链的展示多种受体的嵌合抗原受体T细胞的免疫磁珠纯化。

Leucine zipper-based immunomagnetic purification of CAR T cells displaying multiple receptors.

作者信息

James Scott E, Chen Sophia, Ng Brandon D, Fischman Jacob S, Jahn Lorenz, Boardman Alexander P, Rajagopalan Adhithi, Elias Harold K, Massa Alyssa, Manuele Dylan, Nichols Katherine B, Lazrak Amina, Lee Nicole, Roche Aoife M, McFarland Alexander G, Petrichenko Angelina, Everett John K, Bushman Frederic D, Fei Teng, Kousa Anastasia I, Lemarquis Andri L, DeWolf Susan, Peled Jonathan U, Vardhana Santosha A, Klebanoff Christopher A, van den Brink Marcel R M

机构信息

Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Weill Cornell Medical College, New York, NY, USA.

出版信息

Nat Biomed Eng. 2024 Dec;8(12):1592-1614. doi: 10.1038/s41551-024-01287-3. Epub 2024 Dec 23.

Abstract

Resistance to chimaeric antigen receptor (CAR) T cell therapy develops through multiple mechanisms, most notably antigen loss and tumour-induced immune suppression. It has been suggested that T cells expressing multiple CARs may overcome the resistance of tumours and that T cells expressing receptors that switch inhibitory immune-checkpoint signals into costimulatory signals may enhance the activity of the T cells in the tumour microenvironment. However, engineering multiple features into a single T cell product is difficult because of the transgene-packaging constraints of current gene-delivery vectors. Here we describe a cell-sorting method that leverages leucine zippers for the selective single-step immunomagnetic purification of cells co-transduced with two vectors. Such 'Zip sorting' facilitated the generation of T cells simultaneously expressing up to four CARs and coexpressing up to three 'switch' receptors. In syngeneic mouse models, T cells with multiple CARs and multiple switch receptors eliminated antigenically heterogeneous populations of leukaemia cells coexpressing multiple inhibitory ligands. By combining diverse therapeutic strategies, Zip-sorted multi-CAR multi-switch-receptor T cells can overcome multiple mechanisms of CAR T cell resistance.

摘要

对嵌合抗原受体(CAR)T细胞疗法的耐药性是通过多种机制产生的,最显著的是抗原丢失和肿瘤诱导的免疫抑制。有人提出,表达多种CAR的T细胞可能克服肿瘤的耐药性,并且表达能将抑制性免疫检查点信号转换为共刺激信号的受体的T细胞可能增强肿瘤微环境中T细胞的活性。然而,由于当前基因递送载体的转基因包装限制,将多种特性设计到单个T细胞产品中很困难。在这里,我们描述了一种细胞分选方法,该方法利用亮氨酸拉链对用两种载体共转导的细胞进行选择性单步免疫磁纯化。这种“拉链分选”有助于生成同时表达多达四种CAR并共表达多达三种“开关”受体的T细胞。在同基因小鼠模型中,具有多种CAR和多种开关受体的T细胞消除了共表达多种抑制性配体的白血病细胞的抗原异质性群体。通过结合多种治疗策略,拉链分选的多CAR多开关受体T细胞可以克服CAR T细胞耐药性的多种机制。

相似文献

5
Engineered CD47 protects T cells for enhanced antitumour immunity.工程化 CD47 保护 T 细胞以增强抗肿瘤免疫。
Nature. 2024 Jun;630(8016):457-465. doi: 10.1038/s41586-024-07443-8. Epub 2024 May 15.

本文引用的文献

5
CTLA-4 tail fusion enhances CAR-T antitumor immunity.CTLA-4 尾融合增强 CAR-T 抗肿瘤免疫。
Nat Immunol. 2023 Sep;24(9):1499-1510. doi: 10.1038/s41590-023-01571-5. Epub 2023 Jul 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验